Home LiteratureArticle Details
PMID: 27465244 Published · ppublish English Journal Article

Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network.

Journal of autism and developmental disorders ·Vol. 46 ·No. 10 ·2016-10-00 ·页码 3369-76

Bilder DA, Bakian AV, Stevenson DA, Carbone PS, Cunniff C, Goodman AB, McMahon WM, Fisher NP, Viskochil D

Abstract

Neurofibromatosis type 1 (NF1) is an inherited neurocutaneous disorder associated with neurodevelopmental disorders including autism spectrum disorder (ASD). The frequency of ASD/NF1 co-occurrence has been subject to debate since the 1980s. This relationship was investigated in a large population-based sample of 8-year-old children identified with ASD (N = 12,271) by the Centers for Disease Control and Prevention's Autism and Developmental Disabilities Monitoring (ADDM) Network. Twenty-two (1-in-558) children with ASD had diagnosed NF1, exceeding NF1 general population estimates by four to five fold. Children with ASD/NF1 versus ASD without NF1 were significantly less likely to receive a community-based ASD diagnosis (p = 0.04) and understand non-verbal communication (p = 0.001). These findings underscore the importance of including social-communication ability among relevant developmental concerns in children with NF1.

Keywords
Autism Children Developmental disabilities Neurofibromatosis Non-verbal communications
MeSH 主题词
Autism Spectrum Disorder/diagnosis,epidemiology Centers for Disease Control and Prevention, U.S./standards Child Community Networks/standards Developmental Disabilities/diagnosis,epidemiology Diagnostic and Statistical Manual of Mental Disorders Female Humans Male Neurodevelopmental Disorders/diagnosis,epidemiology Neurofibromatosis 1/diagnosis,epidemiology Nonverbal Communication Prevalence United States/epidemiology
作者与单位
共 9 位作者,点击展开单位 / ORCID
Bilder Deborah A
Utah Autism Research Program, Department of Psychiatry, University of Utah, 650 Komas Drive, Suite 206, Salt Lake City, UT, 84108, USA. deborah.bilder@hsc.utah.edu.
Bakian Amanda V
Utah Autism Research Program, Department of Psychiatry, University of Utah, 650 Komas Drive, Suite 206, Salt Lake City, UT, 84108, USA.
Stevenson David A
Division of Medical Genetics, University of Utah, Salt Lake City, UT, USA. | Division of Medical Genetics, Stanford University, California, USA.
Carbone Paul S
Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
Cunniff Christopher
Department of Pediatrics, University of Arizona, Tucson, AZ, USA. | Division of Medical Genetics, Weill Cornell Medical College, New York, USA.
Goodman Alyson B
National Center on Birth Defects and Developmental Disabilities, Center for Disease Control and Prevention, Atlanta, GA, USA.
McMahon William M
Department of Psychiatry, University of Utah, Salt Lake City, UT, USA.
Fisher Nicole P
Department of Psychiatry, University of Utah, Salt Lake City, UT, USA.
Viskochil David
Division of Medical Genetics, University of Utah, Salt Lake City, UT, USA.
Article Info
Journal
Journal of autism and developmental disorders
Abbr.
J Autism Dev Disord
ISSN
1573-3432
Corresponding email
Published
2016-10-00
页码
3369-76
Language
English
Country/Region
United States
NLM ID
7904301
基金资助
Intramural CDC HHS · CC999999 · United States
NCBDD CDC HHS · UR3 DD000685 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com